Prostate Cancer Clinical Trials in Massachusetts

Showing 101-120 of 278 trials

Aberrant Gene Expression Prostate Carcinoma

NCT00868803

The goal of the study is to gain a better understanding of the molecular changes responsible for causing prostate cancer and that examination of tissue and blood samples will help in the development of improved screening and therapeutic approaches.

Prostate Cancer

Lahey Clinic5,000 participantsStarted Apr 1995

Burlington, Massachusetts, United States

RECRUITINGNA26 miles

Jump: MR Simulation For Radiation Therapy Master Protocol

NCT04545957

This is a master protocol for a prospective Phase I-II study evaluating feasibility and efficacy of incorporating magnetic resonance imaging (MRI) simulation into the planning of radiation treatments.

Prostate CancerRecurrent AdenocarcinomaLiver Cancer+1 more

Brigham and Women's Hospital86 participantsStarted Oct 2020

Boston, Massachusetts, United States • Boston, Massachusetts, United States

COMPLETEDPhase 126 miles

Trial of ARV-110 and Abiraterone in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

NCT05177042

Phase 1b study to assess the combination of ARV-110 and abiraterone in patients with metastatic prostate cancer with rising PSA values on abiraterone.

Prostate Cancer Metastatic

Arvinas Androgen Receptor, Inc.45 participantsStarted Feb 2022

Santa Monica, California, United States • New Haven, Connecticut, United States • Fort Myers, Florida, United States +15 more locations

Aberrant Gene Expression Prostate Carcinoma

Jump: MR Simulation For Radiation Therapy Master Protocol

Trial of ARV-110 and Abiraterone in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Prostate Cancer Trials in Other Cities

Hypofractionated Stereotactic Body Radiation Therapy as a Boost to the Prostate

Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy

Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Experiment to Assess Preferences for Novel Hormonal Therapy and Androgen-deprivation Therapy in Prostate Cancer Patients

Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions

Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors

MGD019 DART® Protein in Unresectable/Metastatic Cancer

Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone Acetate

A Study of Copanlisib Combined With Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer

A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors

A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer

LTFU for All Cell and Gene Therapy Studies

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer

Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer

Other Conditions in Massachusetts